高雄長庚紀念醫院解剖病理科

返回首頁 > 醫師介紹

姓名：	劉婷婷(Liu Ting-Ting)

學歷：	慈濟大學醫學系, 2010

經歷：	2022.12 部定助理教授 2022.07~迄今高雄長庚紀念醫院解剖病理科副主任 2016.10~迄今高雄長庚紀念醫院解剖病理科主治醫師 2014.08~2016.09 高雄長庚紀念醫院檢驗醫學科住院醫師 2010.08~2014.07 高雄長庚紀念醫院解剖病理科住院醫師

現職：	副主任/助理教授級主治醫師

教職：	義守大學兼任助理教授

信箱：

研究計畫：

2020/02-2021/12 CMRPG8C0991-CMRPG8C0993 3年計畫

錯配修復相關基因畸變及其對胃腸道間質瘤微環境免疫調節的影響：結合靶向基因組測序和免疫組織化學染色分析

2013/11-2016/12 CMRPG8K0381

脂類異化作分解代謝相關基因群之區分表達在胃腸道基質瘤意涵:獨立再驗證已發表基因轉錄體之分析

重要著作：

<ol>
	<li>Ting-Ting Liu, Huey-Ling You, Shao-Wen Weng, Yu-Ching Wei, Hock-Liew Eng and Wan-Ting Huang*. Recurrent Amplification at 13q34 Targets at CUL4A, IRS2, and TFDP1 As an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma. PLoS One. 2015 Dec 18;10(12) (SCI; IF=3.057; Multidisciplinary sciences 11/63)</li>
	<li>Ting-Ting Liu, Shao-Wen Weng, Ming-Chung Wang, Wan-Ting Huang*. Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy. APMIS 2016 Mar 14;124(3):216-20. (SCI; IF= 1.933; Pathology 37/78)</li>
	<li>You HL, Liu TT, Weng SW, Chen CH, Wei YC, Eng HL, Huang WT*. Association of IRS2 overexpression with disease progression in intrahepatic cholangiocarcinoma. Oncol Lett. 2018 Oct;16(4):5505-5511. (SCI; IF= 1.664; Oncology 193/222) (Co-first author)</li>
	<li>Li CF, Liu TT, Wang JC, Yu SC, Chen YY, Fang FM, Li Ws, Huang HY. Hydroxysteroid 11-b dehydrogenase 1 overexpression with copy-number gain and missense mutations in primary gastrointestinal stromal tumors. J Clin Med. 2018 Nov 1;7(11). pii: E408. doi: 10.3390/jcm7110408  <tt>(SCI, IF=5.583; G</tt>eneral & internal, co-first author*<tt>)</tt></li>
	<li>Huang HS, Liao CK, Liu TT, You HL, Wang MC, Huang WT*. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression. Hum Pathol. 2018 Oct;80:145-151. (SCI; IF= 3.125; Pathology 19/79)</li>
</ol>

Ting-Ting Liu, Huey-Ling You, Shao-Wen Weng, Yu-Ching Wei, Hock-Liew Eng and Wan-Ting Huang*. Recurrent Amplification at 13q34 Targets at CUL4A, IRS2, and TFDP1 As an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma. PLoS One. 2015 Dec 18;10(12) (SCI; IF=3.057; Multidisciplinary sciences 11/63)
Ting-Ting Liu, Shao-Wen Weng, Ming-Chung Wang, Wan-Ting Huang*. Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy. APMIS 2016 Mar 14;124(3):216-20. (SCI; IF= 1.933; Pathology 37/78)
You HL, Liu TT, Weng SW, Chen CH, Wei YC, Eng HL, Huang WT*. Association of IRS2 overexpression with disease progression in intrahepatic cholangiocarcinoma. Oncol Lett. 2018 Oct;16(4):5505-5511. (SCI; IF= 1.664; Oncology 193/222) (Co-first author)
Li CF, Liu TT, Wang JC, Yu SC, Chen YY, Fang FM, Li Ws, Huang HY. Hydroxysteroid 11-b dehydrogenase 1 overexpression with copy-number gain and missense mutations in primary gastrointestinal stromal tumors. J Clin Med. 2018 Nov 1;7(11). pii: E408. doi: 10.3390/jcm7110408 (SCI, IF=5.583; General & internal, co-first author^*)
Huang HS, Liao CK, Liu TT, You HL, Wang MC, Huang WT*. TP53 mutations in peripheral mature T and NK cell lymphomas: a whole-exome sequencing study with correlation to p53 expression. Hum Pathol. 2018 Oct;80:145-151. (SCI; IF= 3.125; Pathology 19/79)

[ 返回上一頁 ]